. 2006 Jul;43(7):e38. doi: 10.1136/jmg.2005.037507

Table 2 ³¹P‐MRS data from occipital lobes and calf muscle of the proband (case IV‐4) harbouring the 13042G→A/ND5 mtDNA mutation.

	Occipital lobes				Calf muscle
	[PCr] (mM)	[Pi] (mM)	[ADP] (μM)	PP (mM⁻¹)	PCr (mM) rest	Pi (mM) rest	Post‐exercise TC PCr (s)
Case (IV‐4)	3.79*	1.69*	37*	49*	27.2	4.16	55*

Control
(mean (SD))	4.57 (0.19)	1.36 (0.13)	27 (2)	81 (5)	27.9 (1.12)	4.02 (0.56)	19 (4)
(range)	(4.16 to 4.78)	(1.11 to 1.50)	(24 to 32)	(74 to 90)	(25.5 to 29.2)	(3.12 to 4.80)	(11 to 27)

*Outside the normal range.

MRS, magnetic resonance spectroscopy; PCr, phosphocreatine; Pi, inorganic phosphate; PP, phosphorylation potential ( = [ATP]/[ADP]×[Pi]); TC PCr, time constant of phosphocreatine resynthesis rate after exercise.

Table 2 31P‐MRS data from occipital lobes and calf muscle of the proband (case IV‐4) harbouring the 13042G→A/ND5 mtDNA mutation.

Table 2 ³¹P‐MRS data from occipital lobes and calf muscle of the proband (case IV‐4) harbouring the 13042G→A/ND5 mtDNA mutation.